JUVENILE PARKINSONS-DISEASE AND ITS RESPONSE TO L-DOPA THERAPY

被引:2
|
作者
ASKENASY, JJM [1 ]
MENDELSON, L [1 ]
KEREN, O [1 ]
BRAUN, Z [1 ]
机构
[1] TEL AVIV UNIV,LOEWENSTEIN REHABIL HOSP,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL
关键词
Childhood appearance; circadian fluctuations; dystonic foot onset; early "on-off phenomena; familial incidence; low dose levodopa responsiveness;
D O I
10.1007/BF02251243
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Four youngsters, between the ages of 13-27 years, presented dystonic foot. Two to three years following the appearance of the dystonic foot, cogwheel rigidity and tremor appeared on the dystonic foot side. Treatment with low doses of levodopa/carbidopa consistently reversed the symptoms. "On-off" phenomena appeared in the first years of treatment and persisted for the entire period of 5 to 15 years of illness. No parkinsonian signs were present when the dystonic foot appeared. Based on our observations and on a review of the literature, we conclude that responsiveness to low doses of L-dopa is the major maker of juvenile Parkinson's disease. © 1990 Springer-Verlag.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [31] L-DOPA THERAPY OF PARKINSONS DISEASE - PLASMA L-DOPA CONCENTRATION, THERAPEUTIC RESPONSE, AND SIDE EFFECTS
    MUENTER, MD
    TYCE, GM
    MAYO CLINIC PROCEEDINGS, 1971, 46 (04) : 231 - &
  • [32] IMPROVED THERAPEUTIC RESPONSE TO L-DOPA IN PARKINSONS-DISEASE, WHEN COMBINED WITH BROMOCRIPTINE
    ULM, G
    NERVENARZT, 1981, 52 (02): : 116 - 120
  • [33] EVALUATION OF L-DOPA THERAPY IN PARKINSONS DISEASE
    MONES, RJ
    ELIZAN, TS
    SIEGEL, GJ
    NEW YORK STATE JOURNAL OF MEDICINE, 1970, 70 (18) : 2309 - &
  • [34] EXCRETION OF L-DOPA AND ITS METABOLITES IN URINE OF PARKINSONS DISEASE PATIENTS RECEIVING L-DOPA THERAPY
    ROUTH, JI
    BANNOW, RE
    FINCHAM, RW
    STOLL, JL
    CLINICAL CHEMISTRY, 1971, 17 (09) : 867 - +
  • [35] SEROTONERGIC NEURONS ARE NOT INVOLVED IN ACTION OF L-DOPA IN PARKINSONS-DISEASE
    MELAMED, E
    HEFTI, F
    LIEBMAN, J
    SCHLOSBERG, AJ
    WURTMAN, RJ
    NATURE, 1980, 283 (5749) : 772 - 774
  • [36] L-DOPA IMPROVES COLOR-VISION IN PARKINSONS-DISEASE
    BUTTNER, T
    KUHN, W
    PATZOLD, T
    PRZUNTEK, H
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 7 (01) : 13 - 19
  • [37] LONG-TERM RESULTS WITH L-DOPA IN PARKINSONS-DISEASE
    BARBEAU, A
    UNION MEDICALE DU CANADA, 1975, 104 (01): : 32 - 38
  • [38] TREATMENT OF PARKINSONS-DISEASE WITH ORPHENADRINE ALONE AND IN COMBINATION WITH L-DOPA
    BASSI, S
    ALBIZZATI, MG
    CALLONI, E
    SBACCHI, M
    FRATTOLA, L
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1986, 40 (07): : 273 - 275
  • [39] SPEECH CHANGES IN PARKINSONS-DISEASE DURING TREATMENT WITH L-DOPA
    WOLFE, VI
    GARVIN, JS
    BACON, M
    WALDROP, W
    JOURNAL OF COMMUNICATION DISORDERS, 1975, 8 (03) : 271 - 279
  • [40] UNUSUAL SYMPTOMS IN PARKINSONS-DISEASE - POSITIVE EFFECTS OF L-DOPA
    MORELMAROGER, A
    THERME, F
    THERAPIE, 1978, 33 (01): : 129 - 130